Microglial Phagocytosis and Its Regulation: A Therapeutic Target in Parkinson’s Disease?

Microglial Phagocytosis and Its Regulation: A Therapeutic Target in Parkinson’s Disease?

The role of phagocytosis in the neuroprotective function of microglia has been appreciated for a long time, but only more recently a dysregulation of this process has been recognized in Parkinson’s disease (PD). Indeed, microglia play several critical roles in central nervous system (CNS), such as c...

Full description

Bibliographic Details
Main Authors:	Elzbieta Janda, Laura Boi, Anna R. Carta
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2018-04-01
Series:	Frontiers in Molecular Neuroscience
Subjects:	microglia phagocytosis cytokines alpha-synuclein parkinson
Online Access:	http://journal.frontiersin.org/article/10.3389/fnmol.2018.00144/full

Similar Items

Metabolic regulation of microglial phagocytosis: Implications for Alzheimer's disease therapeutics
by: Izabela Lepiarz-Raba, et al.
Published: (2023-10-01)

Microglial Phagocytosis—Rational but Challenging Therapeutic Target in Multiple Sclerosis
by: Maria V. Pinto, et al.
Published: (2020-08-01)

MicroRNAs as Regulators of Phagocytosis
by: Wojciech Gierlikowski, et al.
Published: (2022-04-01)

The Mechanism and Function of Glia in Parkinson's Disease
by: Xinguo Zhang, et al.
Published: (2022-05-01)

The role of microglial autophagy in Parkinson’s disease
by: Rui Zhu, et al.
Published: (2022-11-01)

MICROGLIAL PHAGOCYTOSIS IN RATS WITH DIFFERENT MODELS OF ALZHEIMER'S DISEASE
by: A. Nefedova, et al.
Published: (2023-02-01)

Monocyte Function in Parkinson's Disease and the Impact of Autologous Serum on Phagocytosis
by: Ruwani S. Wijeyekoon, et al.
Published: (2018-10-01)

Temporal Evolution of Inflammation and Neurodegeneration With Alpha-Synuclein Propagation in Parkinson's Disease Mouse Model
by: Thuy Thi Lai, et al.
Published: (2021-10-01)

α-Synuclein propagation leads to synaptic abnormalities in the cortex through microglial synapse phagocytosis
by: Dayana Pérez-Acuña, et al.
Published: (2023-10-01)

The Role of Microglial Phagocytosis in Ischemic Stroke
by: Junqiu Jia, et al.
Published: (2022-01-01)

Evidence of Inflammation in Parkinson’s Disease and Its Contribution to Synucleinopathy
by: Thuy Thi Lai, et al.
Published: (2022-01-01)

Potential Effects of Leukotriene Receptor Antagonist Montelukast in Treatment of Neuroinflammation in Parkinson’s Disease
by: Johan Wallin, et al.
Published: (2021-05-01)

Preliminary analysis of hippocampus synaptic apoptosis and microglial phagocytosis induced by severe restraint stress
by: Shingo Enomoto, et al.
Published: (2023-03-01)

Propofol suppresses microglial phagocytosis through the downregulation of MFG-E8
by: Xiaoying Cai, et al.
Published: (2021-01-01)

Identification of methylation-regulated genes modulating microglial phagocytosis in hyperhomocysteinemia-exacerbated Alzheimer’s disease
by: Xianwei Wang, et al.
Published: (2023-10-01)

Microglial Implication in Parkinson’s Disease: Loss of Beneficial Physiological Roles or Gain of Inflammatory Functions?
by: Cynthia Lecours, et al.
Published: (2018-08-01)

Antioxidant Nanoparticles for Concerted Inhibition of α-Synuclein Fibrillization, and Attenuation of Microglial Intracellular Aggregation and Activation
by: Nanxia Zhao, et al.
Published: (2020-02-01)

Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson’s Disease
by: Yunna Li, et al.
Published: (2021-10-01)

Immunoregulation of microglial polarization: an unrecognized physiological function of α-synuclein
by: Na Li, et al.
Published: (2020-09-01)

The involvement of α-synucleinopathy in the disruption of microglial homeostasis contributes to the pathogenesis of Parkinson’s disease
by: Yongzhen Miao, et al.
Published: (2024-01-01)

Modeling Parkinson’s Disease Neuropathology and Symptoms by Intranigral Inoculation of Preformed Human α-Synuclein Oligomers
by: Laura Boi, et al.
Published: (2020-11-01)

Inhibition of Calpain Attenuates Degeneration of Substantia Nigra Neurons in the Rotenone Rat Model of Parkinson’s Disease
by: Vandana Zaman, et al.
Published: (2022-11-01)

The Peripheral Inflammatory Response to Alpha-Synuclein and Endotoxin in Parkinson's Disease
by: Alice J. White, et al.
Published: (2018-11-01)

Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis
by: Amanda eSierra, et al.
Published: (2013-01-01)

A Novel Microfluidic Cell Co-Culture Platform for the Study of the Molecular Mechanisms of Parkinson’s Disease and other Synucleinopathies
by: João Tiago Fernandes, et al.
Published: (2016-11-01)

Regulators of phagocytosis as pharmacologic targets for stroke treatment
by: Jian Cheng, et al.
Published: (2023-08-01)

Interrogation of human microglial phagocytosis by CRISPR genome editing
by: Jason Cheng-Yu Chang, et al.
Published: (2023-07-01)

Rifampicin and Its Derivative Rifampicin Quinone Reduce Microglial Inflammatory Responses and Neurodegeneration Induced In Vitro by α-Synuclein Fibrillary Aggregates
by: Leonardo Acuña, et al.
Published: (2019-07-01)

Galectin-1 circumvents lysolecithin-induced demyelination through the modulation of microglial polarization/phagocytosis and oligodendroglial differentiation
by: Mariana Rinaldi, et al.
Published: (2016-12-01)

BK Channel-Mediated Microglial Phagocytosis Alleviates Neurological Deficit After Ischemic Stroke
by: Shuxian Huang, et al.
Published: (2021-07-01)

Neuroglial Senescence, α-Synucleinopathy, and the Therapeutic Potential of Senolytics in Parkinson’s Disease
by: Sean J. Miller, et al.
Published: (2022-04-01)

Hydrogen-Rich Saline Regulates Microglial Phagocytosis and Restores Behavioral Deficits Following Hypoxia-Ischemia Injury in Neonatal Mice via the Akt Pathway
by: Ke H, et al.
Published: (2020-09-01)

Genetic ablation of Gpnmb does not alter synuclein-related pathology
by: Robert Brendza, et al.
Published: (2021-11-01)

Microglia affect α-synuclein cell-to-cell transfer in a mouse model of Parkinson’s disease
by: Sonia George, et al.
Published: (2019-08-01)

Rationale for Therapeutic Silencing of Alpha-Synuclein in Parkinson’s Disease
by: Demetrius M. Maraganore
Published: (2011-05-01)

Astrocytic CXCL5 hinders microglial phagocytosis of myelin debris and aggravates white matter injury in chronic cerebral ischemia
by: Qian Cao, et al.
Published: (2023-05-01)

Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson’s Disease
by: Maria Angela Samis Zella, et al.
Published: (2019-01-01)

Clearing the corpses: regulatory mechanisms, novel tools, and therapeutic potential of harnessing microglial phagocytosis in the diseased brain
by: Irune Diaz-Aparicio, et al.
Published: (2016-01-01)

Alpha-synuclein as a biomarker of Parkinson’s disease
by: S. N. Pchelina
Published: (2017-02-01)

Glial phagocytic clearance in Parkinson’s disease
by: Marie-Eve Tremblay, et al.
Published: (2019-04-01)